Altria Group Inc FY2024 Q3 Financial Analysis: Revenue Up 1.2%, Net Income $2.29B

Executive Summary

Altria Group Inc (MO) reported solid financial performance for Q3 FY2024, with revenue increasing marginally by 1.2% compared to the prior year quarter, reaching $5.34 billion. Net income from continuing operations rose significantly to $2.29 billion, reflecting strong operational efficiency and favorable market conditions. The company’s cash flow from operations remained robust at $2.61 billion, supporting ongoing investments and shareholder returns. Despite a challenging macroeconomic environment, Altria demonstrated resilience, with key metrics indicating stability and growth potential.

Management Discussion and Analysis

During Q3 FY2024, Altria maintained its focus on core tobacco products while managing costs effectively. Revenue growth was driven by favorable pricing strategies and volume stability. Operating expenses remained controlled, leading to an operating income of $3.15 billion, up from $3.09 billion in the previous year. The company’s gross profit margin improved slightly, supported by efficient supply chain management. Liquidity remains strong with cash and cash equivalents totaling $1.93 billion, although total liabilities increased due to long-term debt levels. The company continues to prioritize shareholder returns through dividends and share repurchases, with net dividends paid amounting to approximately $1.69 billion in the quarter.

Income Statement Analysis

Revenue and Gross Profit

Revenue increased by 1.2% YoY from $5.27 billion in Q3 FY2023 to $5.34 billion in Q3 FY2024. Gross profit rose by 3.1% from $3.70 billion to $3.81 billion, reflecting improved margin management. Operating income grew by 2.0%, and net income from continuing operations increased by 5.9%, reaching $2.29 billion. Earnings per share remained stable at $1.34, with a slight decrease in weighted average shares outstanding.

Key Ratios and Trends

The net profit margin improved from 4.1% to 4.3%, indicating enhanced profitability. The operating margin increased from 58.4% to 58.9%. These improvements suggest effective cost control and pricing strategies. The YoY revenue growth was modest, but net income growth outpaced revenue, highlighting operational leverage. QoQ comparisons show stable performance, with slight increases in profitability metrics.

Balance Sheet Analysis

Assets and Liquidity

Total assets decreased slightly from $36.47 billion in FY2023 Q3 to $34.17 billion in FY2024 Q3, primarily due to reductions in intangible assets and investments. Cash and cash equivalents increased from $1.54 billion to $1.90 billion, strengthening liquidity. Total current assets stood at $3.50 billion, with inventories at $1.10 billion. Long-term investments decreased marginally, and property, plant, and equipment remained stable.

Liabilities and Equity

Total liabilities increased from $39.83 billion to $37.59 billion, mainly driven by a rise in long-term debt from $23.97 billion to $23.57 billion. Total stockholders’ equity turned negative, at approximately -$3.47 billion, reflecting accumulated deficits and treasury stock holdings. The company’s leverage remains high, with net debt at $23.26 billion, but liquidity ratios suggest manageable debt levels relative to cash flow.

Cash Flow Analysis

Operating cash flow was strong at $2.61 billion, slightly down from $2.97 billion in the previous year but still indicative of healthy core operations. Capital expenditures were minimal at $31 million, supporting ongoing maintenance. Dividends paid totaled approximately $1.69 billion, and share repurchases amounted to $680 million, reflecting ongoing shareholder return policies. Financing activities resulted in net cash outflows of nearly $2.94 billion, mainly due to debt repayments and dividends. The net change in cash was a modest increase of $92 million, ending the period with $1.93 billion in cash.

Ratios & DuPont Analysis

Net profit margin improved slightly to 4.3%. Return on assets (ROA) increased from 0.6% to 6.7%, driven by higher net income and stable asset base. Return on equity (ROE) remains negative due to accumulated deficits, at approximately -66%. Asset turnover ratio improved marginally, indicating efficient utilization of assets. The equity multiplier remains high, reflecting significant leverage. Overall, profitability ratios suggest moderate operational efficiency amid high leverage.

Risk Factors

Altria faces regulatory risks related to tobacco legislation and potential taxation increases. Market competition from alternative nicotine products and e-cigarettes poses a threat to traditional tobacco sales. Operational risks include supply chain disruptions and regulatory compliance costs. Financial risks stem from high leverage and debt levels, which could impact liquidity if cash flows decline. Macro risks include inflationary pressures and economic downturns affecting consumer spending.

Notes & Additional Commentary

Q3 FY2024 results reflect stable core business performance with no significant one-time items. The slight increase in revenue and net income indicates resilience despite macroeconomic headwinds. The negative equity position warrants monitoring, especially regarding debt management and asset valuation. The company’s focus on shareholder returns remains consistent, with ongoing dividends and buybacks supporting investor confidence.

Investment Implications

Short-term opportunities include capitalizing on stable cash flows and dividend payments. Long-term risks involve regulatory changes and high leverage, which could pressure financial stability. The company’s diversified product portfolio and strong cash position provide a buffer against market volatility. A balanced outlook suggests cautious optimism, emphasizing the importance of monitoring regulatory developments and debt levels for sustained growth.